“New Medications & FDA Updates 2018”
Event Navigation
Download a copy of this content.
HealthTrust presents…“New Medications & FDA Updates 2018”
In 2018, there were 59 new molecular entities and 2 new recombinant therapies approved by the FDA for use in the United States as well as several FDA drug safety alerts released: licensed pharmacists need to have knowledge of these new medications and warnings, including their mechanisms of action, dosing, adverse effects and drug interactions. This session will provide a summary review of all new medications approved by the FDA in 2018. Pharmacists will become more competent in these medications and increase their understanding of the warnings, so they can appropriately apply to their daily practice.
Learning Objectives for Pharmacists | At the end of this session, participants should be able to:
- List the medications that were FDA-approved in 2018
- Describe the indications and mechanisms of action of the new medications
- Review adverse effects and patient safety information for these new medications
- Relate the medications FDA-approved in 2018 with those approved previously with similar indications
- Discuss important patient counseling and monitoring parameters for newly approved medications
- Identify drug safety warnings that were published by the FDA in 2018
Learning Objectives for Pharmacy Technicians | At the end of this session, participants should be able to:
- Review appropriate storage instructions for the newly approved medications
- Discuss unique preparation instructions for these new medications
Presenter:
Suzannah Kokotajlo, PharmD | Pediatric Clinical Pharmacist | Morristown Medical Center
Target audience: Pharmacists & Pharmacy Techs
Continuing Education Information: 1.0 contact hours approved for Pharmacists and Pharmacist Technicians. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE Universal Activity Numbers for this activity are 0863-9999-19-085-L01-P and 0863-9999-19-085-L01-T. The activity is approved for 1 hour (.1 CEUs) of continuing education credit to pharmacists and pharmacist technicians who attend the webinar and complete the online evaluation.
Note about CE credit: If you plan to obtain credit, stay until the end of the presentation to receive the verification code you will need to obtain your continuing education credit. A reminder that CE credit is individual. No group credit is available. Each person must register for this session and attend the webinar for 40 minutes or longer in order to receive an email after the event with instructions on how to apply for continuing education credit. Please do not share the code or forward the email you receive to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. Also, please note: If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
Effective June 1, 2019: Belmont College of Pharmacy no longer issues paper/electronic statements of credit for CE activities. ACPE (our accrediting body) policy states paper and/or electronic statements of credit may no longer be distributed directly to learners as proof of ACPE credit. The official record of credit may be located in the learner’s e-profile in CPE Monitor at www.nabp.net.
A participant, sponsor, faculty member or other individual wanting to file a grievance with respect to any aspect of a program sponsored or co-sponsored by the Belmont COP may contact the Dean of Belmont University College of Pharmacy in writing at david.gregory@belmont.edu. The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level of review.
